"Aspen hit a jackpot": SA Pharmaceutical Firm Strikes a Deal to Produce J&J Vaccines for African Countries

"Aspen hit a jackpot": SA Pharmaceutical Firm Strikes a Deal to Produce J&J Vaccines for African Countries

  • Pharmaceutical companies Johnson & Johnson and Aspen have signed a deal that will see Aspen manufacturing vaccines locally
  • The US-based pharmaceutical firm has given Aspen its intellectual property and will also provide the materials needed to produce the jabs
  • South Africans think the new deal is merely a money-making scheme and people will be forced to get vaccinated

PAY ATTENTION: Click “See First” under the “Following” tab to see Briefly News on your News Feed!

JOHANNESBURG - In a historic move, South African pharmaceutical company Aspen is set to manufacture 1.3 billion coronavirus vaccines for the African continent.

This comes after an agreement was reached with Johnson & Johnson that will allow Aspen to produce the J&J jabs using materials supplied by the US pharmaceutical giant.

Aspen, Johnson and Johnson, Covid-19 vaccines, coronavirus, Aspenovax
Aspen will be producing its own Covid19 vaccines using Johnson & Johnson's intellectual property. Images: Jeremy Moeller & Chandan Khann
Source: Getty Images

Johnson & Johnson has granted Aspen an intellectual property licence that will allow Aspen to produce its own branded vaccine that will be called Aspenovax, according to a report by News24.

Read also

Over 50s stand a chance to win R100k if they get vaccinated before Christmas, guaranteed R200 grocery vouchers

Subject to the conclusion of a formal agreement between the companies, the transfer of rights and supply of drug substances will last until December 2026.

PAY ATTENTION: Never miss breaking news – join Briefly News' Telegram channel!

Stephen Saad, Aspen CEO, says the company is grateful for the opportunity granted by J&J and that will address the inequality of Covid19 vaccines in Africa, according to SABCNews.

"It [has] really given us the confidence to boost our capacity from 300 to over 400 next year. By end of next year we get to 700 million. It's still short of our aspiration target of 1.3 billion,” said Saad.

Under the agreement, Aspen is also given the licence to produce new vaccines that J&J produces.

South Africans think the Aspen/J&J deal is about money

Briefly News put together some thoughts from South Africans regarding the deal between Aspen and J&J, here's what they had to say:

Read also

"I'm joining AfriForum": South Africans back AfriForum stance against mandatory vaccination

@Bonginko01 said:

"Aspen hit a jackpot with these #vaccines. There's money to be made for those who are awake, the share is 80% up."

@king_ngcobo said:

"China is donating a billion vaccines to Africa... Looks like we going to need a lot more variants to accommodate for also these vaccines."

@chomoulierfarm said:

"And make some serious cash in the process whilst forcing governments to force citizens to accept no culpability should something go wrong."

@Mbatha_Dumi said:

"Aspenovax from another USA company this means more profits for US-based Pharmaceutical companies."

@KimoreeNews said:

"Aspen and their doctors including our President must hold a press conference and clarify the Vaccine confusion."

@motheoAircons said:

"Money-making schemes to poor African people... They want to have a share... Since they saw that people are making money in Africa... Why would they be so keen on having their name on it? If they don't want to make money?"

Read also

Family Meeting: Ramaphosa says SA will remain on alert level 1

Omicron: Ramaphosa accuses African countries of acting like colonisers over travel ban

Briefly News previously reported that President Cyril Ramaphosa is currently on a state visit to Nigeria. Speaking to reporters there, he likened the African countries that have placed travel bans on South Africa to colonisers.

Egypt, Mauritius, Rwanda and Seychelles have implemented travel bans against South Africa, as well as neighbouring southern African countries. These travel restrictions were instituted in response to the new Omicron variant of Covid-19.

Ramaphosa's trip will continue next week to Senegal and Ghana, where he will promote free trade and African unity, EWN reports.

Source: Briefly News

Online view pixel